Bratton Capital Management, L.P.
Bratton Capital Management, L.P. reported 1 US-listed holding worth $40.8 million in its 13F for the quarter ended 30 June 2026, filed 11 August 2026. Its largest: Aquestive Therapeutics Inc. (100.0%). Against the quarter before, it opened 0 positions, added to 0, trimmed 0 and sold out of 0.
Reported holdings$40.8M+0.2% on Q1 2026
Positions1as many as Q1 2026
The largest ten100.0%of its reported holdings
Latest 13FQ2 2026filed 11 August 2026
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What its reported holdings returned
Held through each quarter, the holdings it reported returned -16.5% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.
Its reported holdingsThe S&P 500
Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Aquestive Therapeutics Inc. AQST | 9.8M | $40.8 million | 100.00% | no change |
Every US-listed position in the fund's 13F for the quarter ended 30 June 2026, by the value it reported.